Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
137.47
+6.81 (5.21%)
At close: Oct 28, 2025, 4:00 PM EDT
138.00
+0.53 (0.39%)
After-hours: Oct 28, 2025, 7:58 PM EDT

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $116.74M in the quarter ending September 30, 2025, with 51.86% growth. This brings the company's revenue in the last twelve months to $402.19M, up 50.50% year-over-year. In the year 2024, GeneDx Holdings had annual revenue of $305.45M with 50.79% growth.

Revenue (ttm)
$402.19M
Revenue Growth
+50.50%
P/S Ratio
9.68
Revenue / Employee
$402,190
Employees
1,000
Market Cap
3.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

WGS News

More News